- Home
- IRWD vs NVX Comparison
IRWD vs NVX Comparison
Compare IRWD & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- NVX
- Stock Information
- Founded
- IRWD 1998
- NVX 2012
- Country
- IRWD United States
- NVX Australia
- Employees
- IRWD N/A
- NVX N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- NVX Industrial Machinery/Components
- Sector
- IRWD Health Care
- NVX Miscellaneous
- Exchange
- IRWD Nasdaq
- NVX Nasdaq
- Market Cap
- IRWD 150.9M
- NVX 169.3M
- IPO Year
- IRWD 2010
- NVX N/A
- Fundamental
- Price
- IRWD $0.65
- NVX $1.11
- Analyst Decision
- IRWD Buy
- NVX
- Analyst Count
- IRWD 5
- NVX 0
- Target Price
- IRWD $4.94
- NVX N/A
- AVG Volume (30 Days)
- IRWD 3.0M
- NVX 95.0K
- Earning Date
- IRWD 05-07-2025
- NVX 01-01-0001
- Dividend Yield
- IRWD N/A
- NVX N/A
- EPS Growth
- IRWD N/A
- NVX N/A
- EPS
- IRWD N/A
- NVX N/A
- Revenue
- IRWD $317,676,000.00
- NVX $5,854,424.00
- Revenue This Year
- IRWD N/A
- NVX $66.66
- Revenue Next Year
- IRWD N/A
- NVX $2,366.64
- P/E Ratio
- IRWD N/A
- NVX N/A
- Revenue Growth
- IRWD N/A
- NVX N/A
- 52 Week Low
- IRWD $0.53
- NVX $0.81
- 52 Week High
- IRWD $7.11
- NVX $2.73
- Technical
- Relative Strength Index (RSI)
- IRWD 39.10
- NVX 40.24
- Support Level
- IRWD $0.55
- NVX $1.15
- Resistance Level
- IRWD $0.65
- NVX $1.42
- Average True Range (ATR)
- IRWD 0.07
- NVX 0.09
- MACD
- IRWD 0.02
- NVX -0.03
- Stochastic Oscillator
- IRWD 37.04
- NVX 1.19
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.